Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension
NCT ID: NCT03566329
Last Updated: 2019-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
90 participants
INTERVENTIONAL
2018-07-10
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnesium Treating Subarachnoid Hemorrhage Vasospasm
NCT04613960
Mgso4 as Neuroprotective in Post Traumatic Brain Injury
NCT04646876
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
NCT05325580
Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation
NCT03573999
Comparative Study Between Hydrocortisone and Mannitol in Treatment of Postdural Puncture Headache
NCT02760862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Magnesium sulphate
50 mg/kg over 10 minutes loading followed by 15mg/kg/hr infusion
Magnesium sulphate
Magnesium sulphate 50 mg/kg over 10 minutes loading followed by 15mg/kg/hr infusion. .
lidocaine hydrochloride
1.5mg/kg loading followed by 2mg/kg/hr infusion
Lidocaine Hydrochloride
lidocaine hydrochloride 1.5mg/kg loading followed by 2mg/kg/hr infusion
NaCl 0.9% normal saline
Normal saline infusion with the same rate as the study drugs
Normal saline
Normal saline infusion with the same rate of infusion as the study drugs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnesium sulphate
Magnesium sulphate 50 mg/kg over 10 minutes loading followed by 15mg/kg/hr infusion. .
Lidocaine Hydrochloride
lidocaine hydrochloride 1.5mg/kg loading followed by 2mg/kg/hr infusion
Normal saline
Normal saline infusion with the same rate of infusion as the study drugs
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled patients for brain tumor excision.
Exclusion Criteria
* Signs of increased intracranial pressure or allergy to any of the used drugs.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahmed Mohamed ELbadawy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed ELbadawy
Ahmed Mohamed ELbadawy- Clinical investigator , Cairo University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed ELbadawy, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of medicine- Cairo University- Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed ELbadawy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed ELbadawy
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.